These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion. Gilder AS; Jones KA; Hu J; Wang L; Chen CC; Carter BS; Gonias SL J Biol Chem; 2015 Jun; 290(24):14798-809. PubMed ID: 25837250 [TBL] [Abstract][Full Text] [Related]
4. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII. Mukherjee J; DeSouza LV; Micallef J; Karim Z; Croul S; Siu KW; Guha A Cancer Res; 2009 Nov; 69(22):8545-54. PubMed ID: 19903856 [TBL] [Abstract][Full Text] [Related]
5. The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cells. Estrada-Bernal A; Lawler SE; Nowicki MO; Ray Chaudhury A; Van Brocklyn JR J Neurooncol; 2011 May; 102(3):353-66. PubMed ID: 20938717 [TBL] [Abstract][Full Text] [Related]
6. The location of estrogen receptor variant ER-α36 is associated with the invasion of glioblastoma. Li H; Ge N; Guan X; Han C; Li Y; Shen L; Chen M; Zhang B; Qu C; Zou W Steroids; 2023 Jun; 194():109224. PubMed ID: 36924815 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide. Sharifi Z; Abdulkarim B; Meehan B; Rak J; Daniel P; Schmitt J; Lauzon N; Eppert K; Duncan HM; Petrecca K; Guiot MC; Jean-Claude B; Sabri S Clin Cancer Res; 2019 Dec; 25(24):7594-7608. PubMed ID: 31540977 [TBL] [Abstract][Full Text] [Related]
8. FHL2 interacts with EGFR to promote glioblastoma growth. Sun L; Yu S; Xu H; Zheng Y; Lin J; Wu M; Wang J; Wang A; Lan Q; Furnari F; Cavenee W; Purow B; Li M Oncogene; 2018 Mar; 37(10):1386-1398. PubMed ID: 29321665 [TBL] [Abstract][Full Text] [Related]
9. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells. Hu J; Jo M; Cavenee WK; Furnari F; VandenBerg SR; Gonias SL Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15984-9. PubMed ID: 21896743 [TBL] [Abstract][Full Text] [Related]
11. CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration. Wei Y; Vellanki RN; Coyaud É; Ignatchenko V; Li L; Krieger JR; Taylor P; Tong J; Pham NA; Liu G; Raught B; Wouters BG; Kislinger T; Tsao MS; Moran MF Mol Cancer Res; 2015 Jul; 13(7):1119-29. PubMed ID: 25784717 [TBL] [Abstract][Full Text] [Related]
12. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Feldkamp MM; Lala P; Lau N; Roncari L; Guha A Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712 [TBL] [Abstract][Full Text] [Related]
13. Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas. Higgins DMO; Caliva M; Schroeder M; Carlson B; Upadhyayula PS; Milligan BD; Cheshier SH; Weissman IL; Sarkaria JN; Meyer FB; Henley JR BMC Cancer; 2020 Dec; 20(1):1213. PubMed ID: 33302912 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830 [TBL] [Abstract][Full Text] [Related]
15. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia activates enhanced invasive potential and endogenous hyaluronic acid production by glioblastoma cells. Chen JE; Lumibao J; Blazek A; Gaskins HR; Harley B Biomater Sci; 2018 Mar; 6(4):854-862. PubMed ID: 29485655 [TBL] [Abstract][Full Text] [Related]
17. Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth. Hu L; Shen D; Liang D; Shi J; Song C; Jiang K; Menglin Ren ; Du S; Cheng W; Ma J; Li S; Bi X; Barr MP; Fang Z; Xu Q; Li W; Piao H; Meng S Cancer Lett; 2020 Nov; 493():156-166. PubMed ID: 32860853 [TBL] [Abstract][Full Text] [Related]
18. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis. Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039 [TBL] [Abstract][Full Text] [Related]
19. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma. Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878 [TBL] [Abstract][Full Text] [Related]
20. The epidermal growth factor receptor variant type III mutation frequently found in gliomas induces astrogenesis in human cerebral organoids. Kim HM; Lee SH; Lim J; Yoo J; Hwang DY Cell Prolif; 2021 Feb; 54(2):e12965. PubMed ID: 33283409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]